Antiviral Agents and Vaccines

Содержание

• April 8-10
• April 12
• June 6
• August 14
• September 8
• September 24
• References
• 30 Virology
• Discovery of the SARS Virus
• Initial Research
• Coronaviridae
• SARS Co-V
• Genome Sequence
• Antiviral Agents and Vaccines
• Antiviral Drugs
• Vaccines
• Outlook
• References
• Routes of Transmission
• Patient Factors in Transmission
• Asymptomatic Patients
• Symptomatic Patients
• The Unsuspected Patients
• High-Risk Activities
• Transmission during Quarantine
• Introduction
• Global Spread
• Hong Kong
• Other Countries
• Eradication
• Outlook
• Introduction
• International Coordination
• Management of SARS in the post-outbreak period
• National Measures
• Legislation
• Quarantine after Discharge
• Infection Control in Healthcare Settings
• General Measures
• Protective Measures
• Special Settings
• Intensive Care Units
• Intubating a SARS Patient
• Anesthesia
• Triage
• Internet Sources
• After the Outbreak
• Conclusion
• 108 Case Definition
• WHO Case Definition
• Suspect case
• Reclassification of cases
• CDC Case Definition
• 112 Diagnostic Tests
• Introduction
• Laboratory tests
• Virus isolation
• Antibody detection
• Interpretation
• Limitations
• Biosafety considerations
• Clinical Presentation and Diagnosis
• Clinical Presentation
• Diagnosis
• Clinical Course
• Histopathology
• Lung Biopsy
• Postmortem Findings
• Discharge and Follow-up
• Psychosocial Issues
• References
• 144 SARS Treatment
• Antibiotic therapy
• Antiviral therapy
• Ribavirin
• Alternative medicine
• Immunomodulatory therapy
• Other immunomodulators
• Assisted ventilation
• Invasive mechanical ventilation
• Clinical outcomes
• Appendix 1
• A standardized treatment protocol for adult SARS in Hong Kong
• Appendix 2
• A treatment regimen for SARS in Guangzhou, China
• References
• 168 Pediatric SARS
• Clinical Manifestation